Binance, one of the world’s largest cryptocurrency exchanges, announced that it has decided to delist certain trading pairs as part of its periodic reviews aimed at maintaining the quality of spot market transactions and providing users with a more efficient trading environment. The exchange stated that following recent evaluations based on various criteria such as low liquidity and trading volume, seven spot trading pairs will be delisted.
According to a statement by Binance, trading on the ACX/USDC, ALGO/BTC, CVC/USDC, LPT/USDC, ONG/BTC, RVN/USDC, and XRP/BNB trading pairs will be suspended as of July 24, 2026, at 06:00. These trading pairs will no longer be available on the Binance Spot platform after that date.
The exchange emphasized that the removal of certain trading pairs does not mean that the related crypto assets have been completely delisted. Users will continue to be able to buy and sell assets such as ACX, ALGO, CVC, LPT, ONG, RVN, and XRP through other trading pairs that remain supported on Binance Spot. Therefore, only specific pairs will be removed, and the general trading access of the tokens on the platform will continue.
Binance also announced that its Spot Trading Bots service, which operates based on the trading pairs to be removed, will be terminated on the same date and time. In this context, investors using automated trading strategies are advised to update or cancel their bots in advance to prevent potential losses.
Cryptocurrency exchanges periodically review and remove trading pairs with low trading volume or insufficient liquidity from their platforms. This practice is said to aim at improving market efficiency, enhancing price formation, and protecting the user experience.
Experts emphasize that investors should closely monitor such announcements, and point out that users of automated trading systems, in particular, should check their open orders and bot settings for the pairs being delisted. Binance is expected to continue similar periodic reviews in the future.
*This is not investment advice.
